Definition:
The Sleep Aids market encompasses a diverse array of over-the-counter (OTC) medications and supplements designed to aid individuals in managing sleep-related disorders, including insomnia, sporadic sleep disruptions, and jetlag resulting from adjusting to different time zones. This market includes products containing ingredients such as Doxylamine Succinate, Diphenhydramine, Melatonin, and herbal remedies. Notable sleep aid products include Natrol Melatonin, Vitafusion, Alteril, Unisom SleepTabs, and Kalms. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.
Additional information:
The Sleep Aids market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.
Notes: Data was converted from local currencies using average exchange rates of the respective year.
Most recent update: Mar 2024
Source: Statista Market Insights
Most recent update: Mar 2024
Source: Statista Market Insights
The Sleep Aids market in Bhutan is experiencing steady growth due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors.
Customer preferences: In Bhutan, there has been a noticeable shift in customer preferences towards sleep aids. With the increasing awareness about the importance of a good night's sleep for overall well-being, consumers are actively seeking products that can help them achieve better sleep quality. This change in attitude is driven by a growing emphasis on health and wellness, as well as an increasing number of people experiencing sleep-related issues.
Trends in the market: One of the key trends in the Sleep Aids market in Bhutan is the rising popularity of natural and herbal sleep aids. Consumers are becoming more conscious about the potential side effects of synthetic sleep aids and are opting for natural alternatives. This trend is in line with the global shift towards natural and organic products in various industries. Another trend observed in the market is the increasing demand for sleep aids that address specific sleep-related issues. For instance, products targeting insomnia, sleep apnea, and restless leg syndrome are gaining traction in Bhutan. This trend highlights the growing awareness and understanding of different sleep disorders among consumers, leading to a demand for specialized solutions.
Local special circumstances: Bhutan is known for its emphasis on Gross National Happiness (GNH) rather than Gross Domestic Product (GDP). This unique approach to development places a strong emphasis on overall well-being, including mental health. As a result, the Sleep Aids market in Bhutan benefits from a supportive environment that encourages the use of sleep aids as a means to improve quality of life.
Underlying macroeconomic factors: Bhutan's growing economy and increasing disposable income are contributing to the growth of the Sleep Aids market. As people's purchasing power increases, they are more willing to spend on products that can improve their sleep quality. Additionally, the expanding middle class in Bhutan is becoming more health-conscious, leading to a higher demand for sleep aids. Furthermore, the government's focus on healthcare and wellness is also driving the growth of the Sleep Aids market. Bhutan has been investing in healthcare infrastructure and promoting preventive healthcare measures. This has led to an increased awareness about sleep disorders and the importance of quality sleep, further fueling the demand for sleep aids. In conclusion, the Sleep Aids market in Bhutan is experiencing growth due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. With the increasing emphasis on health and wellness, the demand for sleep aids is expected to continue rising in the coming years.
Most recent update: Mar 2024
Source: Statista Market Insights
Data coverage:
Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.Modeling approach / Market size:
Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.Notes: Based on data from IMF, World Bank, UN and Eurostat
Most recent update: Sep 2024
Source: Statista Market Insights